首页> 美国卫生研究院文献>AAPS PharmSciTech >Drying Using Supercritical Fluid Technology as a Potential Method for Preparation of Chitosan Aerogel Microparticles
【2h】

Drying Using Supercritical Fluid Technology as a Potential Method for Preparation of Chitosan Aerogel Microparticles

机译:使用超临界流体技术干燥制备壳聚糖气凝胶微粒的潜在方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Supercritical fluid technology offers several advantages in preparation of microparticles. These include uniformity in particle size, morphology, and drug distribution without degradation of the product. One of the recent advantages is preparation of porous aerogel carrier with proper aerodynamic properties. In this study, we aimed to prepare chitosan aerogel microparticles using supercritical fluid (SCF) technology and compare that with microparticles produced by freeze drying (FD). Loading the prepared carriers with a model drug (salbutamol) was also performed. Comparisons of the particle properties and physicochemical characterizations were undertaken by evaluating particle size, density, specific surface area, and porosity. In vitro drug release studies were also investigated. The effect of many variables, such as molecular weight of chitosan oligomers, concentrations of chitosan, and concentrations of tripolyphosphate on the release, were also investigated. Chitosan aerogels were efficiently produced by SCF technology with an average particle size of 10 μm with a tapped density values around 0.12 g/mL, specific surface area (73–103) m2/g, and porosity (0.20–0.29) cc/g. Whereas, microparticles produced by FD method were characterized as cryogels with larger particle size (64 microns) with clear cracking at the surface. Sustained release profile was achieved for all prepared microparticles of salbutamol produced by the aforementioned methods as compared with pure drug. The results also demonstrates that chitosan molecular weight, polymer concentration, and tripolyphosphate concentration affected the release profile of salbutamol from the prepared microparticles. In conclusion, SCF technology was able to produce chitosan aerogel microparticles loaded with salbutamol that could be suitable for pulmonary drug delivery system.
机译:超临界流体技术在制备微粒方面具有​​多个优势。这些包括粒径,形态和药物分布的均匀性,而不会降解产物。最近的优点之一是制备具有适当空气动力学性质的多孔气凝胶载体。在这项研究中,我们旨在使用超临界流体(SCF)技术制备壳聚糖气凝胶微粒,并将其与冷冻干燥(FD)产生的微粒进行比较。还用模型药物(沙丁胺醇)装载制备的载体。通过评估粒径,密度,比表面积和孔隙率,比较了颗粒性质和理化特性。还研究了体外药物释放研究。还研究了许多变量,如壳聚糖低聚物的分子量,壳聚糖的浓度和三聚磷酸盐的浓度对释放的影响。壳聚糖气凝胶是通过SCF技术有效生产的,平均粒径为10μm,振实密度值约为0.12 g / mL,比表面积(73-103)m 2 / g和孔隙率( 0.20–0.29)cc / g。而通过FD方法生产的微粒则被表征为具有较大粒径(64微米)且表面明显开裂的冰晶。与纯药物相比,通过上述方法生产的沙丁胺醇的所有制备微粒均实现了持续释放。结果还表明,壳聚糖的分子量,聚合物浓度和三聚磷酸盐浓度影响沙丁胺醇从制备的微粒中的释放曲线。总之,SCF技术能够生产负载沙丁胺醇的壳聚糖气凝胶微粒,该微粒可能适用于肺部药物输送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号